Author

Julie B. Løhde

Observed names: Julie Bondgaard Loehde, Julie Bondgaard Løhde

Institutions: Aarhus University, Aarhus University Hospital, Steno Diabetes Center Aarhus

Observed institutions: Aarhus University, Aarhus University Hospital, Steno Diabetes Center Aarhus

OpenAlex ID: A5117077966

Real‐world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP ‐ 1RA ‐based weight‐loss therapies

2025 · Reimar W. Thomsen, Aurélie Mailhac, et al. · Diabetes Obesity and Metabolism · 231

Reduced Activity of Soluble Fibroblast Activation Protein (sFAP) Represents a Biomarker of Aggressive Disease in Lymphoid Malignancies

2025 · Jonas Klejs Hemmingsen, Marie Hairing Enemark, et al. · International Journal of Molecular Sciences · 1

DCMax - A novel Delayed C max Drug Delivery System for Improved Chronotherapy

2026 · Kushagr Punyani, Julie Bondgaard Loehde, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Author response for "Real‐world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP ‐ 1RA ‐based weight‐loss therapies"

2025 · Reimar W. Thomsen, Aurélie Mailhac, et al. · Publons reviews and discussion

Works count: 4

Citation count: 232

H-index: 1

I10-index: 1